LATIN AMERICA ONCOLOGY DEVICE MARKET ANALYSIS

Latin America Oncology Device Market, by Chemotherapy Administration (Gravity Chemotherapy Administration, Syringe Chemotherapy Administration, Pump Chemotherapy Administration, and Others), by Accessories and Consumables (Infusion Sets, Venous Access (Ports, Needles), Catheter (CVC, PIC), Needle Connectors, Syringe Filters, and Software), by Age Group (Pediatric (Infant, Children, Teenager) and Adults), by End User (Private Hospitals/Clinics (General Hospitals with Oncology Centers, Specialized Hospitals, Specialized Clinics), Public Hospitals/ Clinics (General Hospitals with Oncology Centers, Hospitals, Clinics), and Others (Homecare Settings, Research Institutes)), and by Country (Brazil, Mexico, and Chile) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Press Release : Latin America Oncology Device Market

Request Sample Download PDF

Oncology devices play a major role in healthcare, owing to factors such as increasing incidence of cancer in Latin America. For instance, according to the Global Cancer Observatory’s 2019 report, in Chile, around 53,365 new cases of cancer were recorded in 2018, and around 28,443 individuals died due to cancer in 2018. Moreover, according to the same source, in 2018, around 6,576 people suffered from prostate cancer which was major type of cancer among all the types of cancer cases observed in Chile.

Furthermore, key companies are focused on research and development of technologically advanced devices for the treatment of cancer due to increase in incidence in the region, which is expected to drive the market growth. For instance, in January 2019, Medtronic PLC announced that the Journal of Thoracic Oncology published 12-month results of the NAVIGATE study, the largest, prospective, multicenter trial evaluating electromagnetic navigation bronchoscopy (ENB) procedures using the super Dimension navigation system to aid in lung cancer diagnosis, staging, and treatment. NAVIGATE included a key finding that 65% of the patients diagnosed by physicians with primary lung cancer were at early stages (Stage I or II) of the disease

The Latin America oncology device market size is estimated to be valued at US$ 31.08 million in 2020 and is expected to exhibit a CAGR of 5.5 % over the forecast period (2020-2027).

Figure 1. Latin America Oncology Device Market, by Market Value (US$ Mn), 2016-2027

The increasing incidence of cancer is driving demand for oncology devices for the treatment of cancer. For instance, according to the International Agency for Research on Cancer’s 2019 report, in Mexico, around 190,667 patients were newly diagnosed with cancer and around 83,476 patients died due to cancer in 2018. According to the same source, breast cancer was the major type of cancer in Mexico with around 27,283 new cases of breast cancer in 2018.

Moreover, according to the International Agency for Research on Cancer’s 2019 report, in Mexico, around 190,667 patients were newly diagnosed with cancer and around 83,476 patients died due to cancer in 2018. According to the same source, breast cancer was the major type of cancer in Mexico with around 27,283 new cases of breast cancer in 2018.

Latin America Oncology Device Market – Impact of Coronavirus (Covid-19) Pandemic

Following the outbreak of COVID-19 in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it a public health emergency. According to the World Health Organization’s report, the manifestation of the coronavirus (COVID-19) has resulted in more than 14 million infected individuals worldwide as of July 24, 2020.

Key players operating in the Latin America oncology devices market are facing major challenges on various fronts due to the COVID-19 pandemic. The major challenges include supply of raw materials due to irregularities in transportation. Furthermore, distributors are experiencing irregular demand for products from the retailers due to rising incidence of COVID -19.

Moreover, rising Covid-19 infections globally, there are rising consequences such as shortage in essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected patients. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients who may require critical care. Moreover, there is an urgent need for rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others).

Figure 2. Latin America Oncology Device Market Share (%), by Country, 2020

Among countries, Mexico oncology devices market is expected to exhibit significant growth, owing to increasing distribution agreements between key players to enhance their presence in the country. For instance, in July 2016, Novosanis, a medical device company based in Belgium, announced a distribution partnership with Distribuidora GAP. As part of this agreement, Distribuidora GAP will sell Novosanis’ Colli-PeeTM, a medical device suited for collection of first void urine, in Mexico. Colli-PeeTM device allows easier and more patient-friendly detection of the Human papillomavirus that can lead to cervical cancer.

Moreover, increasing prevalence of cancer is expected to drive the Chile oncology devices market growth. For instance, in 2015, according to the National Center for Biotechnology Information 2015, the estimated annual incidence of cancer in Chile is around 35,000 new cancer cases per year, with adjusted incidence rates of 226 and 180 per 100,000 male and female inhabitants, respectively.

Key Players

Major players operating in the Latin America oncology device market include Medtronic plc, ACE Medical, VOGT Medical, Becton, Dickinson and Company, Smiths Medical, Inc., Samtronic Industria e Comercio LTDA, Codan Argus AG, B. Braun Melsungen AG, Medical Components, Inc, Fresenius SE & Co. KGaA, Baxter International Inc, EuroLife Healthcare Pvt. Ltd, and Micrel Medical Devices.

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.

What we provide:

  • Customized Market Research Services
  • Industry Analysis Services
  • Business Consulting Services
  • Market Intelligence Services
  • Long term Engagement Model
  • Country Specific Analysis

Contact Us:

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Email: sales@coherentmarketinsights.com